title: Efavirenz-associated Stevens-Johnson syndrome.
authors.forename: R
authors.initials: R
authors.lastname: Colebunders
authors.forename: T
authors.initials: T
authors.lastname: Vanwolleghem
authors.forename: P
authors.initials: P
authors.lastname: Meurrens
authors.forename: F
authors.initials: F
authors.lastname: Moerman
mesh_terms: D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D048588:Benzoxazines; D003521:Cyclopropanes; D003622:Dapsone / Q000009:adverse effects; D005260:Female; D006801:Humans; D010078:Oxazines / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D003622:Dapsone; C098320:efavirenz